Evidence map›Paper›PMID 34135964›Full record

ArticleJournal of oncology2021

A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study.

Filadelfiya Zvinovski, Julie A Stephens, Bhuvaneswari Ramaswamy, Raquel E Reinbolt, Anne M Noonan, Jeffrey Bryan VanDeusen, Robert Wesolowski, Daniel G Stover, Nicole Olivia Williams, Sagar D Sardesai and 5 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Filadelfiya ZvinovskiThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0002-7715-3457
Julie A StephensThe Ohio State University Center for Biostatistics, Columbus, OH, USA.
Bhuvaneswari RamaswamyThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0002-2822-8379
Raquel E ReinboltThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0002-1250-2222
Anne M NoonanThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0001-8083-8492
Jeffrey Bryan VanDeusenThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0002-4171-5649
Robert WesolowskiThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0003-0606-0648
Daniel G StoverThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0001-9003-8165
Nicole Olivia WilliamsThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0002-0339-1612
Sagar D SardesaiThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.
Laxmi MehtaThe Ohio State University Medical Center, Division of Cardiology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0003-3493-1930
Randi ForakerWashington University in Saint Louis, Center for Population Health Informatics, St. Louis, MO, USA.ORCID https://orcid.org/0000-0001-9255-9394
Martha GulatiUniversity of Arizona College of Medicine-Phoenix, Division of Cardiology, Phoenix, AZ, USA.ORCID https://orcid.org/0000-0003-0735-9756
Maryam LustbergThe Ohio State University Medical Center, Division of Medical Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0001-8559-5645
Allison M QuickThe Ohio State University Medical Center, Department of Radiation Oncology Columbus, Columbus, OH, USA.ORCID https://orcid.org/0000-0002-2260-6586
The Ohio State University Wexner Medical Center · USThe Ohio State University · USUniversity of Arizona · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to determine the feasibility and preliminary efficacy of a cardiac rehabilitation (CR) intervention in the breast cancer population.

methodsThis single-arm feasibility study evaluated a 14-week CR intervention program in breast cancer survivors. Feasibility was defined as completion of at least 30/36 sessions of the program without serious adverse events (SAE) in 80% of patients. Secondary endpoints included the change in VO2 max, cardiovascular disease (CVD) risk factors, Duke Activity Secondary Index (DASI), Brief Fatigue Inventory (BFI), and QLQ-C30. All outcomes were reported as mean change and compared using paired

resultsA total of 25 patients were enrolled in the study. 18 patients of the 25 enrolled (72%) completed the 14 weeks program without SAE. The overall adherence to the study protocol was 60%. Of the 18 participants who did not withdraw from the program, 15 (83%) adhered to the study protocol and completed 30 or more sessions. There was a nonsignificant improvement in VO2 max (mean Δ0.5,

conclusionA CR intervention in breast cancer survivors had high adherence in those who were able to complete the 14-week program. The program significantly improved patient reported physical activity, fatigue, and quality of life (QoL), without significant improvement in CVD risk factors. Implications for cancer patients are that early implementation of a CR program should be considered by practitioners as it improves QoL and exercise tolerance in breast cancer survivors.

Identifiers

PMID34135964
PMCPMC8178006
OpenAlexW3170828393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.